Research and Markets: Global Multiple Myeloma Drugs Market 2015-2019 with Celgene, J & J, Novartis, Onyx Pharmaceuticals , Sanofi & Takeda Pharmaceutical Dominating
Research and Markets: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014
Research and Markets: T-Cell Lymphomas - Pipeline Review, H2 2014
FDA Approves BLINCYTO™ (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Amgen To Webcast Investor Meeting At Upcoming American Society of Hematology (ASH) 56th Annual Meeting And Exposition
Rising interest rates have taken their toll, but as the Fed delays dialing back on stimulus, investors are poised to recapture some of their losses.
The broad stock runup in the first half of 2013 was a boon to ClearBridge Aggressive Growth, and comanager Evan Bauman says that the fund is well-positioned for the market going forward.
We look at how a biotech ETF holds up in an iffy climate for those stocks.